BCRXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
BIOCRYST PHARMACEUTICALS INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$8.07+0.28 (+3.59%)
Close on Oct 19, 2026
- Market cap
- $2.14B
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Biocryst Pharmaceuticals's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 5, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 5, 2026 | Aug 5, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 25, 2026 | Jun 29, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 11, 2026 | Jun 12, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 6, 2026 | SEC EDGAR |
| Current report | 8-K | May 6, 2026 | May 6, 2026 | SEC EDGAR |
| Current report | 8-K | May 4, 2026 | May 4, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 11, 2026 | Apr 23, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Feb 26, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 26, 2026 | Feb 26, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 23, 2026 | Jan 23, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 12, 2026 | Jan 12, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 9, 2026 | Jan 9, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 12, 2025 | Dec 12, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 9, 2025 | Dec 11, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 3, 2025 | Dec 3, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 4, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 3, 2025 | Nov 3, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 14, 2025 | Oct 14, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 1, 2025 | Oct 1, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 11, 2025 | Aug 11, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 5, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 4, 2025 | Aug 4, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 25, 2025 | Jul 31, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 7, 2025 | Jul 7, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 27, 2025 | Jun 30, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 27, 2025 | Jun 27, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 23, 2025 | Jun 25, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 11, 2025 | Jun 16, 2025 | SEC EDGAR |
| Current report | 8-K | May 31, 2025 | Jun 4, 2025 | SEC EDGAR |
| Current report | 8-K | May 14, 2025 | May 14, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 6, 2025 | SEC EDGAR |
| Current report | 8-K | May 5, 2025 | May 5, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 30, 2025 | May 1, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 12, 2025 | Apr 24, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 6, 2025 | Apr 10, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 10, 2025 | Mar 11, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 28, 2025 | Mar 4, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Feb 25, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 24, 2025 | Feb 24, 2025 | SEC EDGAR |